{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:30:22Z","timestamp":1790775022895,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008809","name":"University of Ha'il","doi-asserted-by":"publisher","award":["RG-23123"],"award-info":[{"award-number":["RG-23123"]}],"id":[{"id":"10.13039\/501100008809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.phymed.2024.155777","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:20:06Z","timestamp":1717140006000},"page":"155777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Homa","family":"Fatma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Jameel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Jamal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Kuddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouha Saleh","family":"Buali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5302-7934","authenticated-orcid":false,"given":"Insaf","family":"Bahrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-0487","authenticated-orcid":false,"given":"Hifzur R","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phymed.2024.155777_bib0001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamasurg.2021.0546","article-title":"PRISMA reporting guidelines for meta-analyses and systematic reviews","volume":"156","author":"Arya","year":"2021","journal-title":"JAMA Surgery"},{"key":"10.1016\/j.phymed.2024.155777_bib0002","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2014.04.090","article-title":"New role of lupeol in reticence of angiogenesis, the cellular parameter of neoplastic progression in tumorigenesis models through altered gene expression","volume":"448","author":"Avin","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155777_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mvr.2018.10.008","article-title":"Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression","volume":"121","author":"Bhattacharyya","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.phymed.2024.155777_bib0004","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","article-title":"The interplay among miRNAs, major cytokines, and cancer-related inflammation","volume":"20","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.phymed.2024.155777_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jpp\/rgab060","article-title":"Lupeol induces autophagy and apoptosis with reduced cancer stem-like properties in retinoblastoma via phosphoinositide 3-kinase\/protein kinase B\/mammalian target of rapamycin inhibition","volume":"74","author":"Che","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155777_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2024.155777_bib0007","unstructured":"Deeks, J.J., Higgins, J.P.T., Altman, D.G., 2023. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., Welch, V.A. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (Accessed December 31, 2023). Cochrane, 2023. Available from www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.phymed.2024.155777_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-019-00671-9","article-title":"Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: Potential role in the prevention and treatment of inflammation and cancer","volume":"28","author":"Harikrishnan","year":"2020","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.phymed.2024.155777_bib0009","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1248\/bpb.34.517","article-title":"Growth inhibition and apoptosis induced by lupeol, a dietary triterpene, in human hepatocellular carcinoma cells","volume":"34","author":"He","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2024.155777_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC. Med. Res. Methodol."},{"key":"10.1016\/j.phymed.2024.155777_bib0011","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jnatprod.5b01088","article-title":"Lupeol isolated from sorbus commixta suppresses 1\u03b1,25-(OH)2D3-mediated osteoclast differentiation and bone loss in Vitro and in Vivo","volume":"79","author":"Im","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2024.155777_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/09553002.2015.966209","article-title":"Lupeol enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo","volume":"91","author":"Jin","year":"2015","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.phymed.2024.155777_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189628","article-title":"Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-\u03b1","volume":"12","author":"Kangsamaksin","year":"2017","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.phymed.2024.155777_bib0014","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phymed.2024.155777_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116699","article-title":"Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy","volume":"478","author":"Khan","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155777_bib0016","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.24000","article-title":"Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation","volume":"53","author":"Lee","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.phymed.2024.155777_bib0017","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1158\/0008-5472.CAN-07-0801","article-title":"Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155777_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1475-2867-13-108","article-title":"PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma","volume":"13","author":"Liu","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phymed.2024.155777_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40203-022-00131-3","article-title":"Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, \u03b2-catenin and c-FLIP: in silico and in vitro studies","volume":"10","author":"Maurya","year":"2022","journal-title":"In. Silico Pharmacol."},{"key":"10.1016\/j.phymed.2024.155777_bib0021","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/1381612826666200122122804","article-title":"Chemosensitization of therapy resistant tumors: targeting multiple cell signaling pathways by Lupeol, A pentacyclic triterpene","volume":"26","author":"Maurya","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2024.155777_bib0022","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-08-2917","article-title":"Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells","volume":"69","author":"Murtaza","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155777_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.31024\/apj.2018.3.4.4","article-title":"Role of Lupeol as potent inhibitor for the management of inflammatory disorders","volume":"3","author":"Namdeo","year":"2018","journal-title":"Adv. Pharm. J."},{"key":"10.1016\/j.phymed.2024.155777_bib0024","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/br.2013.116","article-title":"Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model","volume":"1","author":"Nitta","year":"2013","journal-title":"Biomed. Rep."},{"issue":"4","key":"10.1016\/j.phymed.2024.155777_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12253-012-9541-9","article-title":"Lupeol, a bioactive triterpene, prevents tumor formation during 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis","volume":"18","author":"Palanimuthu","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"30","key":"10.1016\/j.phymed.2024.155777_bib0026","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1038\/sj.onc.1207641","article-title":"Lupeol modulates NF-kappaB and PI3K\/Akt pathways and inhibits skin cancer in CD-1 mice","volume":"23","author":"Saleem","year":"2004","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.phymed.2024.155777_bib0027","doi-asserted-by":"crossref","first-page":"11203","DOI":"10.1158\/0008-5472.CAN-05-1965","article-title":"A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model","volume":"65","author":"Saleem","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155777_bib0028","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1158\/1078-0432.CCR-07-4413","article-title":"Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis","volume":"14","author":"Saleem","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"33","key":"10.1016\/j.phymed.2024.155777_bib0029","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.18632\/oncotarget.19101","article-title":"Acetyl-lupeolic acid inhibits Akt signaling and induces apoptosis in chemoresistant prostate cancer cells in vitro and in vivo","volume":"8","author":"Schmidt","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.phymed.2024.155777_bib0030","doi-asserted-by":"crossref","unstructured":"Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L.A., 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clin. Res. ed.), 350, g7647. doi:10.1136\/bmj.g7647.","DOI":"10.1136\/bmj.g7647"},{"key":"10.1016\/j.phymed.2024.155777_bib0031","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-11-0916","article-title":"Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy","volume":"17","author":"Siddique","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155777_bib0032","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.lfs.2010.11.020","article-title":"Beneficial health effects of lupeol triterpene: a review of pre-clinical studies","volume":"88","author":"Siddique","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155777_bib0033","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.fct.2016.11.007","article-title":"Enhanced chemoprevention by the combined treatment of pterostilbene and lupeol in B[a]P-induced mouse skin tumorigenesis","volume":"99","author":"Singh","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155777_bib0034","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.phymed.2024.155777_bib0035","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/carcin\/bgq169","article-title":"Specific targeting of Wnt\/\u03b2-catenin signaling in human melanoma cells by a dietary triterpene lupeol","volume":"31","author":"Tarapore","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155777_bib0036","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.phymed.2024.155777_bib0037","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1039\/D2FO00483F","article-title":"Lupeol inhibits the proliferation and migration of MDA-MB-231 breast cancer cells via a novel crosstalk mechanism between autophagy and the EMT","volume":"13","author":"Zhang","year":"2022","journal-title":"Food Funct."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:14:26Z","timestamp":1723648466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324004355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"alternative-id":["S0944711324004355"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155777","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155777"}}